December 19, 2025 · Form 4 insider transaction
Mottola Frank bought 15,000 shares of Supernus Pharmaceuticals, Inc. at $25.30 per share, a transaction worth $379.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2025.